Life Sciences, Pharma

Scroll down

The Pharmaceutical industry, also known as the pharma industry, is a highly regulated sector responsible for the research, development, and production of drugs and other health-related products. Pharma plays a vital role in improving public health and advancing medical science; thus, companies in the pharma sector must comply with laws and regulations that guarantee the safety and efficacy of their products, as well as laws regarding the approval and marketing of drugs, and those for the protection of their intellectual property.

Common legal issues in the pharma sector include patent and trademark litigation, regulatory compliance and product liability. As a consequence, pharma companies must navigate complex and rapidly changing regulations, including those related to clinical trials, drug approvals, and advertising.

Oppenheim provides pharma companies with legal advice and representation on a wide range of issues, including regulatory compliance, intellectual property protection, and litigation. Additionally, Oppenheim helps these companies navigate the complex legal landscape to identify and mitigate legal risks, allowing them to focus on their core mission of improving public health and advancing medical science.

Oppenheim provides array of services, including:

  • Regulatory Compliance
  • Intellectual Property Protection
  • Litigation
  • Mergers and Acquisitions
  • Advertising and Promotion
The pharma industry is heavily regulated, as companies must comply with a range of laws and regulations, including those related to the approval and marketing of drugs, clinical trials, and safety. Oppenheim assists companies in navigating these regulations and ensuring compliance.
Protecting patents, trademarks, and copyrights is critical for the pharma sector, as the development of new drugs is complex and costly. Oppenheim provides legal advice on intellectual property matters and assists with the enforcement of IP rights.
Companies in the pharma sector are frequently involved in disputes, ranging from patent and trademark litigation to product liability claims. Oppenheim provides representation in court and other dispute resolution forums.
Companies in the pharma sector often engage in mergers and acquisitions to grow and expand. Oppenheim assists with the legal aspects of these transactions, including due diligence, contract negotiations, and closing.
The marketing and advertising of drugs is subject to strict regulations, which companies must comply to ensure the safety and efficacy of their products. Oppenheim provides legal advice on advertising and promotion matters, and assists with the development of compliant marketing strategies.

Overall, Oppenheim plays a critical role in helping pharmaceutical companies navigate the complex legal landscape and succeed in this highly regulated and competitive industry.

Companies in this sector have engaged Oppenheim in a variety of issues, such as advising on the Hungarian aspects of the provision of investigational medicines on a compassionate use basis; as well as on various regulatory, licensing, contracting, pricing, marketing authorization and compliance matters. Additionally, our team has helped conduct a mock-down raid regarding compliance with drug promotional regulatory requirements.

Our colleagues specialized in this sector